Learn about Elevated LP(a) and Converging Risk Factors in a Young Woman - A Case Study
You can view this informtion at the following link: https://berkeley.box.com/s/hjwm7avakzflhacx6asktd0zzzq3zk0l
Overview:
Dr. Eveline Stock presents a case study of a young woman with elevated LP(a), to illustrate the 2026 dyslipidemia guidelines for combating lifetime ASCVD risk.
The original presentation of this recording took place on June 8th, 2026.
Presenter
Eveline Oestreicher Stock, MD
Co-Chair, Right Care Initiative Bay Area Silicon Valley University of Best Practices;
Associate Professor and Cardiologist, University of California San Francisco Cardiovascular Care & Prevention Center
Speaker Bio:
Dr. Stock’s expertise in Endocrinology and Cardiology at the University of California San Francisco have informed her exciting work in molecular cardiology. Dr. Stock is a leader in the field of lipoprotein metabolism, and the diagnosis and management of lipoprotein disorders for the prevention of atherosclerotic coronary heart disease. Her research interests include the role of lipoprotein subclasses as predictors of coronary artery disease and myocardial infarction. She is an Associate Professor at UCSF, a practicing cardiologist and lipidologist, and a researcher at the Cardiovascular Research Institute at UCSF. She received her medical education at the Catholic University of Chile and completed her training in endocrine hypertension and residency at Harvard Medical School’s Massachusetts General Hospital. She looks forward to continuing to work with the Right Care Initiative as a means of closing the gap between science and practice to get to zero heart attacks and strokes, especially in vulnerable populations.